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ABSTRACT The PHRI gene of Saccharomyces cerevasiae
encodes the DNA repair enzyme photolyase. Transcription of
PHRI increases in response to treatment of cells with 254-nm
radiation and chemical agents that damage DNA. We report
here the identification of a damage-responsive DNA binding
protein, termed photolyase regulatory protein (PRP), and its
cognate binding site, termed the PHRI upstream repression
sequence, that together regulate induction ofPHRI transcrip-
tion after DNA damage. PRP activity, monitored by electro-
phoretic-mobility-shift assay, was detected in cells during
normal growth but disappeared within 30 min after irradia-
tion. Copper-phenanthroline footprinting of PRP-DNA com-
plexes revealed that PRP protects a 39-base-pair region of
PHRI 5' flanking sequence beginning 40 base pairs upstream
from the coding sequence. A prominent feature of the foot-
printed region is a 22-base-pair palindrome. Deletion of the
PHR1 upstream repression sequence increased the basal level
expression of PHRI in vivo and decreased induction after
exposure of cells to UV radiation or methyl methanesulfonate,
whereas insertion of the PRP binding site between the CYCI
upstream activation sequence and "TATA" sequence reduced
basal level expression and conferred damage responsiveness
upon a reporter gene. Thus these observations establish that
PRP is a damage-responsive repressor ofPHRI transcription.
Exposure of cells to agents that introduce bulky lesions into
DNA results in the enhanced expression of genes encoding
enzymes involved in DNA repair, recombination, and mu-
tagenesis. This phenomenon has been most thoroughly stud-
ied in Escherichia coli in which DNA damage elicits in-
creased transcription of the uvrA, uvrB, uvrD, recA, recN,
and umuDC genes and a number of other genes that partic-
ipate in the SOS response (for reviews, see refs. 1 and 2).
Coordinate expression ofthese genes is achieved through the
interaction of two proteins, LexA, the common repressor of
the SOS genes, and RecA. RecA is activated in response to
DNA damage and in this form stimulates autoproteolysis and
consequent inactivation of LexA. The importance of regu-
lation to both the survival and genetic integrity of E. coli is
apparent in lexA(Ind-) and lexA(Def) mutants. In the former
failure to induce the SOS genes reduces UV survival by three
to four orders of magnitude whereas in the latter constitutive
expression of SOS functions enhances the spontaneous mu-
tation frequency 10- to 20-fold (3, 4).
Enhanced repair capacity, mutagenesis, and recombination
afterDNA damage have also been observed in eukaryotes and
a number of genes have been identified whose mRNAs accu-
mulate at increased levels after DNA damage, although in
general the magnitude of these effects is significantly less than
that in bacterial systems (5-12). Nevertheless at present there
is no strong evidence that regulation of damage-responsive
genes in eukaryotes is mediated by only one or a few tran-
scription regulators. In mammalian cells at least three tran-
scription factors, AP-1, serum-response factor, and NF-KB,
have been implicated in the induction of damage-responsive
genes; however, each ofthese factors also regulates genes that
do not respond to DNA damage (13). In assessing the rele-
vance of such observations to the issue of a coordinated
SOS-like response in eukaryotes, it is important to distinguish
between damage-specific responses and secondary responses
triggered by metabolic changes unrelated to damage process-
ing. We believe that this is best accomplished by focusing
initially on genes encoding proteins involved in DNA repair.
For this reason we have begun to explore the mechanisms of
signal transduction and transcription regulation that culminate
in induction ofthe PHRI gene ofSaccharomyces cerevisiae in
response to DNA damage.
PHRJ encodes the apoprotein of the DNA repair enzyme
photolyase (EC 4.1.99.3), which has only two known functions
(for review, see ref. 14): (i) light-dependent repair of pyrimi-
dine dimers, the primary lesions induced in DNA by UV light,
and (ii) stimulation of nucleotide excision repair, probably by
enhancing the efficiency of dimer recognition by the excision
nuclease. We have reported (15) that transcription ofPHRI is
induced 10- to 20-fold in response to UV radiation, 4-nitro-
quinoline 1-oxide, methyl methanesulfonate, and N-methyl-
N'-nitro-N-nitrosoguanidine but does not respond to either
heat shock or photoreactivating light. Thus induction is a
response to a specific class of DNA lesions, including some
that are not repaired by photolyase. We now report the
identification of a damage-responsive DNA binding protein
and upstream repression sequence (URS) that together medi-
ate induction of PHRI after DNA damage.
MATERIALS AND METHODS
Partial Purification of Photolyase Regulatory Protein (PRP).
PRP was routinely prepared from 5-liter cultures of early
logarithmic-phase cells (1-2 x 107 cells per ml) of S. cerevi-
siae GBS77 (MATa ura3-52 leu2-3,112 rad2; ref. 15) grown in
YPAD medium (16) at 300C. Cells were harvested by cen-
trifugation at 5000 x g, washed with extraction buffer [100
mM Tris HCl, pH 8.0/400 mM (NH4)2SO4/10 mM MgCl2/
10% (vol/vol) glycerol/10 mM 2-mercaptoethanol], sus-
pended in 2.5 ml of extraction buffer per g of cells, and
disrupted by agitation in the presence of glass beads (Mini-
Beadbeater, Biospec Products, Bartlesville, OK). Cell lysis
and all subsequent procedures were performed at 40C in
buffers containing 1 mM phenylmethylsulfonyl fluoride, leu-
peptin at 1 pug/ml, and pepstatin at 1 pug/ml. Cellular debris
Abbreviations: OP-Cu, 1,10-phenanthroline copper; PRP, photo-
lyase regulatory protein; UAS, upstream activation sequence; URS,
upstream repression sequence.
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was removed by centrifugation for 1 hr at 100,000 x g, after
which proteins in the supernatant were precipitated by ad-
dition of (NH4)2504 to a final concentration of 60%o of
saturation. After centrifugation for 30 min at 12,000 x g, the
pellet was suspended in 5 ml of buffer D [20mM Tris HCl, pH
8.0/50 mM (NH4)2SO4/50 mM NaCl/0.2 mM EDTA/10 mM
2-mercaptoethanol/lOo glycerol], dialyzed against the same
buffer, and then loaded onto a 10-ml heparin-Sepharose
column. After washing with 50 ml of buffer D, proteins were
eluted using a 50-ml linear gradient of 100-600 mM
(NH4)2SO4 in buffer D. Fractions consisting of 1.5-2.0 ml of
effluent were tested for binding to the PHRI upstream
regulatory region as described below. Active fractions were
pooled, dialyzed into buffer D containing 50%o glycerol, and
stored at -800C.
For isolation of PRP from irradiated cells, cells from early
logarithmic-phase cultures were collected and irradiated as
described (15). After irradiation the cells were suspended at
a density of 2 x 107 cells per ml in warm YPAD medium and
incubated at 30'C and with shaking for various times prior to
processing as described above.
PRP Binding Assay and Footprinting of the PRP Binding
Site. PRP binding was monitored by the electrophoretic-
mobility-shift assay (17, 18). Radiolabeled substrate was
prepared by standard techniques (19) using [y-32P]ATP and
T4 polynucleotide kinase to label purified PHRI restriction
fragments derived from plasmid pGBS116 (15). Partially
purified PRP (1-6 ,ul) was incubated on ice for 15 min in a
mixture consisting of 0.5x buffer D minus (NH4)2SO4, pep-
statin at 0.5 pug/ml, leupeptin at 0.5 pug/ml, 5 mM 2-mercap-
toethanol, 0.05 mM phenylmethylsulfonyl fluoride, and dou-
ble-stranded poly(dI-dC) at 100 ,ug/ml. Radiolabeled sub-
strate (1-3 ng in 2 p.l) was added and incubation was
continued for 20 min. The entire 20-,ul binding mixture was
loaded onto a 6% polyacrylamide slab gel in 2x TBE (19) and
electrophoresed at 30 mA for 3-5 hr. Bound and free sub-
strate were visualized by autoradiography.
Footprinting of the PRP binding site was accomplished
using 1,10-phenanthroline copper (OP-Cu), a 10-fold scaled-up
binding reaction mixture, and sufficient PRP to retard 60-80%6
of the substrate. After separation ofbound and free substrate,
treatment with OP-Cu was performed in situ as described (20),
and polyacrylamide plugs containing free and bound substrate
were excised from the gel. The substrate was recovered by
electroelution and analyzed on an 8% polyacrylamide/urea gel
in parallel with the products of Maxam-Gilbert sequencing
reactions (19) performed using naive substrate.
Plasmid Constructions and Induction of PHRI Expression.
pGBS116 is a yeast-E. coli shuttle vector that carries a
replication origin from the endogenous yeast 2-pum plasmid,
the URA3 gene of S. cerevisiae, and 634 base pairs (bp) of
PHRI (including 352 bp of 5' flanking sequence) fused in
frame to the coding sequence of the E. coli lacZ gene (15).
pLGA-312 carries the replication origin of the yeast 2-pum
plasmid, the URA3 gene, CYCI upstream activation se-
quences (UASs), and 4 bp of CYCI coding sequence fused to
lacZ (21). Synthetic oligonucleotides used in the construction
of plasmids pGBS145 and pCYC1::URS had the following
sequences: APRP, CTGTGAAACGAATTGTAAAGGT-
TAAYTTGACTGC; SalA, TTCGAGGAAGCAGTCGACT-
TAAACCTTAAGGGG; and SalB, GTCTGTTCTGT-
GAGTCGACTTGTAAAGAGG. The sequence of oligonu-
cleotide APRP is identical to that of PHR1 at positions -22'
to -96' (where the first ATG in the coding sequence ofPHRI
is +1 and its complement is +1'; ref. 22) except for the
absence of the PRP binding site at bases -40' to -78'.
Oligonucleotides SalA and SalB are identical to PHRI at
positions -105 to -73 and -15' to -45', respectively, except
at the underlined positions where engineered base changes
have introduced Sal I sites.
Plasmid pGBS145, in which the PRP binding site is deleted,
was constructed utilizing a derivative of bacteriophage
M13mp8 containing the PHRJ gene. Oligonucleotide APRP
was hybridized to phage DNA and used to prime second-
strand synthesis by the Klenow fragment of E. coli DNA
polymerase I (19). Clones containing the desired deletion were
identified by restriction analysis and standard recombinant
DNA techniques were used to replace the 376-bp Xba I-Bgl II
fragment of pGBS116 (15, 22) with the 337-bp Xba I-Bgl II
fragment containing the deletion. Plasmid pCYC1::URS is a
derivative of pLGA-312 (21) in which the PRP binding site has
been inserted at the unique Xho I site in the upstream regu-
latory region of CYCL. This was accomplished using oligonu-
cleotides SalA and SalB, in conjunction with pGBS116, in a
PCR to synthesize a 91-bp fragment containing the PRP
binding site flanked on each side by a Sal I site. After cleavage
with Sal I, this fragment was ligated to Xho I-digested pLGA-
312. The structures of both pGBS145 and pCYC1::URS were
confirmed by nucleotide sequence analysis. Transformation of
yeast strain GBS76 (Mata ura3-52 leu2-3,112 rad2 phrl) was
carried out as described (15).
P-Galactosidase activity was quantified on cultures of
strain GBS76 carrying various plasmids. Cells were exposed
to 254-nm radiation at 7.5 J/m2 or treated with 2.3 mM methyl
methanesulfonate as described (15). For experiments mea-
suring CYCI promoter activity, strains were grown in syn-
thetic complete medium lacking uracil (16).
RESULTS
The electrophoretic-mobiity-shift assay (17, 18) was used to
identify proteins that bind to the 5' flanking region of PHR1
and are thus candidates for regulators ofPHRI transcription.
In this assay DNA-protein complexes migrate more slowly in
polyacrylamide gels than does free DNA. The binding target
was a 400-bp Pvu II-Bgl II fragment containing 352 bp of 5'
flanking sequence and 48 bp ofPHR1 coding sequence (Fig. 1);
all sequences required for induction ofPHR1 lie downstream
of the Pvu II site (15). When chromatography on heparin-
Sepharose was used to fractionate total yeast protein from
nonirradiated cells, the major binding activity was eluted at
-0.15 M (NH4)2SO4 (Fig. 2, lanes 4-10). We refer to the
binding protein(s) responsible for this activity by the acronym
PRP (forphotolyase regulatoryprotein). Nonlabeled substrate
competed effectively with labeled substrate for PRP binding
whereas OX DNA did not (Fig. 3), indicating that binding is
specific for sequences in the PHRI probe. Protein-substrate
complexes formed with the minor binding activities eluting at
higher ionic strength (Fig. 2, lanes 12-26) were equally sensi-
tive to homologous or heterologous competing DNA and thus
reflect nonspecific interactions (data not shown).
In contrast to the result obtained with nonirradiated cells,









FIG. 1. Restriction map ofthe 400-bpPvu II-Bgl II fragment from
PHRI used as substrate for electrophoretic-mobility-shift assays.
Numbering-is relative to the first base in the PHRI coding sequence.
The hatched box shows the position of the PRP binding site
(URSpHR1) identified in these studies and the sequence shown below
the map is that protected by PRPfrom OP-Cu attack. Arrows indicate
the 22-bp palindrome within the PRP binding site.
Proc. Natl. Acad. Sci. USA 88 (1991)
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FIG. 2. Complexes Oifned between the 400-bp PHRI fragment
and proteins in fractions from heparin-Sepharose chromatography of
crude extracts. A 32P-labeled PNu II-Bgl II fragment was incubated
with 2 ,ul from alternate fractions, and then bound and free substrate
were resolved by electrophoretic-mobility-shift assay and visualized
by atutoradiography. Numbers above each lane indicate the fraction
number relative to the first fraction collected after beginning a
0.1-0.6 M (NH4)2SO4 gradient. Binding activity was not observed in
material that did not bind to the column. F, free DNA. (Upper)
Extracts from nonirradiated cells. (Lower) Extracts from cells har-
vested 1 h after exposure to 254-nm radiation at 10 J/M2.
activity in either column fractions or total crude extracts from
cells harvested 30, 60, or- 90 min after irradiation (Fig. 2 and
data not shown). A low level of binding activity was occa-
sionalty observed in fractions eluting at -0.3 M (NH4)2SO4
(Fig. 2, lanes 12-14); however, this activity differed from that
of PRP from nonirradiated cells in two respects. (i) The
complexes formed with the 400-bp substrate migrate with
significantly different mobility (Fig. 4, lanes 3 and 7). (ii) The
binding activity obtained from irradiated cells disappeared
during a 12-h storage in buffer D supplemented with 0.3 M
(NH4)2SO4, 15% glycerol, and protease inhibitors whereas
PRP activity was stable under these conditions. Further-
more, PRP binding activity could not be reconstituted by
Proc. Natl. Acad. Sci. USA 88 (1991) 11253
combining pooled fractions from -irradiated cells (data not
shown). Therefore, we conclude that irradiated cells do not
contain significant amounts offunctiohal PRP, at least during
the period from 30 to 90 min after irradiation. Significantly,
this is the period ofmaximum accumulation ofPHk1 mRNA
after UV irradiation (15). Due to the instability of the binding
activity from irradiated cells, we have not characterized it
further.
Identification of the Sequences Bound by PRP. The number
and locations of the protein-DNA complexes on the 400-bp
fragment were elucidated by. incubating labeled restriction
fragments derived from the 400-bp Pvu II-BgI II substrate
with partially purified PRP then using the mobility-shift assay
to identify bound fragments. Nar I digestion of the substrate
produced 228-bp and 172-bp fragments among which only the
latter was bound, whereas none of the products of a Nar
I-Hph I digest formed stable complexes with PRP (Fig. 1;
data not shown). Thus the target of PRP binding resides
within the 172-bp Nar I-Bgl II fragment, and Hph I digestion
separates sequences required for binding. The region of the
Nar I-Bgl II fragment in contact with PRP was defined by
OP-Cu footprinting in situ in a polyacrylamide gel followed
by analysis on a DNA sequencing gel; OP-Cu generates
single-strand breaks in the substrate except at positions
where formation of the reactive coordination complex in the
minor groove is inhibited, due either to obstruction by aDNA
binding protein or an unusual helix geometry (23). Compar-
ison of OP-Cu digestion products obtained in the absence or
presence ofPRP revealed a single protected region extending
on the bottom strand shown in Fig. 1 from A-40' to T-78' (Fig.
5) and on the top strand from A78 to T-4 or A-41 (data not
shown). Two features of the protected region are particularly
striking. (i) A 22-bp palindrome, GTGAAAGTATGCT-
TACTTllGAC (underlined characters indicate mismatches),
is found within the protected region and at a slightly off-
center position, extending from G-73 through C52 (Fig. 1).
Such molecular palindromes are frequently seen in binding
sites recognized by dimeric proteins. (ii) The region protected
from OP-Cu is unusually large, encompassing 39 contiguous
base pairs. In addition, substitution of one-half of the dyad
with random sequence reduces PRP binding by at least a
factor of 10 (B. vande Berg and G.B.S., unpublished obser-
vation), indicating that the palindrome likely plays a role in
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FIG. 3. Competition studies on PRP binding. A series of elec-
trophoretic-mobility-shift assays were performed in which PRP was
incubated with various concentrations of unlabeled competing DNA
and, 1 ng of a 32P-labeled Pvu II-Bgl II fragment. The number above
each lane indicates the molar ratio of competitor to the PHR1 probe.
Pvu II-Bgl II indicates that homologous unlabeled probe was used as
competitor, and OX indicates that the competing DNA was a Hae III
digest of uiilabeled phage 4X174 DNA.
FIG. 4. Comparison of the mobility and binding activity of PRP
with that of the binding activity present in irradiated cells. Total
protein from irradiated cells was fractionated by heparin-Sepharose
chromatography and successive fractions were combined so that
each pool represented '20% of the (NH.4SO4 gradient used for
elution. Electrophoretic-mobility-shift assays were performed using
1 ng of 32P-labeled Pvu II-Bgl II fragment and either 5 pl from the
pool indicated or 1 1l of PRP. The arrowhead marks the position of
the complex formed with protein from irradiated cells. Lanes: 1,
binding protein omitted; 2, pool 1; 3, pool 2; 4, pool 3; 5, pool 4; 6,
pool 5; 7, PRP.
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FIG. 5. OP-Cu footprint of the PRP binding site 5' to PHRJ.
PRP-DNA complexes, formed on the 178-bp Nar I-Bgl II fra~gment
(Fig. 1), and nonbound (unprotected) DNA were treated with OP-Cu
in situ (20) and analyzed on a 8% DNA sequencing gel. For the
experiment shown here the fragment was labeled with [y-32P]ATP on
the 5'end at the Bg1 II site and thus the footprint is visualized on' the
bottom strand relative to the PHRJ coding sequence. Lanes: 1 and
2, A+G and T+C, respectively, products of Maxam-Gilbert se-
quencing reactions performed on naive DNA; 3, OP-Cu products
from the band containing PRP-DNA complexes; 4, OP-Cu products
from the band containing nonbound DNA. Numbering on the left side
of the figure gives the position in the sequence relative to the,
adenosine in the first ATG of the coding sequence; the bracket and
numbering on the right indicate the region protected by PRP from
OP-Cu attack.
PRP binding. Kuwabara et al. (23) have shown that, with
small ligands such as netropsin, OP-Cu overestimates the
region of ligand-DNA interaction by only 1 or 2 bp; thus it is
likely that the entire region protected by PRP is either in
intimate contact with the .protein or undergoes significant
structural alteration upon PRP binding.
Genetic Evidence That PRP Is a DaaeResponsive Nega-
tive Regulator of PHR1. The fact that PRP binding activity is
present in nondamaged cells but absent from damaged cells
suggests that PRP is a negative regulator ofPHRJ expression.
To test this hypothesis, we compared the expression, in S.
cerevisiae GBS76, of a plasmid-borne PHRJ-lacZ fusion
gene carrying the entire 5' flanking, region of PHRJ
(pGBS116; ref. 15) with that of a similar pla~smid in which the
39-bp PRP binding site -had been deleted (pGBS145). Control
experiments demonstrated that deletion of the PRP binding
site abolished PRP binding in vitro (data not shown). In vivo,
deletion of the PRP binding site increased the basal level of
expresSion of PHRJ by a factor of 7 and reduced the
induction ratio by a factor of 3.5 (Fig. 6>. These, results are
consistent with negative regulation of PHRJ expression by
PRP but also reveal that relief of repression by PRP is not the
sole mechanism through which the damnage-responsive in-
duction ofPHRJ is mediated. In addition deletion of the PRP
binding site has a similar effect on induction after UV
irradiation or treatment with methyl methanesulfonate (Fig.
6), suggesting that PRP responds to multiple damaging agents
that induce different types of lesions in DNA.
The Effect of PRP Binng on Expression from a Heterolo-
gous Promoter. In yeast two types of negatively acting
transcriptional regulatory elements have been identified; one
type corresponds to a classic operator in that it is able to
repress transcription when moved into a heterologous pro-
moter, and the second type functions as a repressor only in
the context ofitsown or similarly regulated genes (24-27). To
determine whether the PRP binding site can function outside
ofthe context ofthe PHRI regulatory region, we constructed
plasmid pCYC1::URS in which a 64-bp oligonucleotide con-
taining the 39-bp PRP-protected region and 25 bp of flanking
sequence was inserted between UAS2 and the transcription
start site of a CYCIJ-acZ fusion gene carried by plasmid
pLGA-312. Control experiments demonstrated that PRP
bound equally well to the 64-bp oligonucleotide and the
400-bp Pvu II-Bgl II fragment (data not shown).
pCYC1::URS was then introduced into strain GBS76 and the
effect on f-galactosidase expression from the fusion gene was
assessed. As can be seen in Fig. 6, the presence of the PRP
binding site has two effects. (i) Basal level expression of the
fusion gene decreases by a factor of 40 compared to that of
the parental plasmid, and (ii) the fusion gene becomes
damage-responsive. The relatively low level of (3-galacto-
sidase activity seen in pCYC1::URS after UV irradiation is
somewhat surprising in view of the fact that the same UV
fluence yields an 11-fold induction of the fusion gene when
expression is directed by the intact PHRI promoter in
pGBS116 (Fig. 6 and ref. 15). Although-we cannot at present
rule out an adverse "spacing effect" due to insertion of the
fiagment containing the PRP binding site, we believe that this
explanation is unlikely in view of previous reports that
insertion of comparable or larger fragments into the identical
location in pLGA-312 or its derivatives does not have similar
effects (25, 28, 29). Rather relief ofrepression by PRP may be
facilitated by additional sequences not present in the inserted
fragment. Similar results have been reported by Sumrada and
Cooper (25) for repression mediated by URSlcAR1 and by
Park and Craig (29) for URSHSP70; when placed in the context
of the CYCI promoter these URSs were unresponsive to
signals that relieved repression mediated by these elements in
their intact homologous promoters. Further experiments are
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FIG. 6. (-Galactosidase (LacZ) activity of promoter fusion plas-
mids used to define the in vivo function ofthe PRP binding site. (Left)
The thin line represents PHRI 5' flanking sequences, the thick line
represents CYCI 5' flanking sequences, the hatched box represents
the PRP binding site, the cross-hatched boxes show UAS1 and UAS2
ofCYCI, and the solid and open boxes represent coding regions from
PHR1 and lacZ, respectively. (Right) 3alactosidase activity is
given for cultures 4 h after treatment with the indicated DNA
damaging agent or after sham treatment as described (15); values are
the mean of at least two experiments and the standard deviation in
aI cases was <15%. Induction ratios are the ratio of(-galactosidase
activity in treated cultures divided by the activity in control cultures.
MMS, methyl methanesulfonate.
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necessary to determine whether additional sequences from
the PHRJ promoter are necessary to obtain full induction.
Nevertheless our results clearly indicate that the PRP binding
site constitutes an authentic operator for PHRI, which we
call URSPHR1, and that this sequence is sufficient to confer
damage responsiveness.
DISCUSSION
In this work we have demonstrated that enhanced expression
of PHRI in response to DNA damage is regulated by a
transcriptional repressor called PRP and its cognate binding
site URSlpHR1. Five observations support this conclusion. (i)
PRP binds to a 39-bp region in the PHRI 5' regulatory region.
(ii) Binding activity is present in extracts from undamaged
cells and disappears within 30 min after exposure of cells to
254-nm radiation. (iii) Complex formation in vitro between
PRP and the PHRI 5' regulatory region is abolished by
deletion of URSPHR1. (iv) Deletion of URSPHR1 leads to 7-fold
increase in the basal level of PHRI expression in vivo and a
3.5 times decrease in the induction ratio after irradiation. (v)
When placed in the context of a heterologous promoter,
URSPHRl represses basal level transcription and confers
damage responsiveness.
Enhanced expression of PHRI is induced by a variety of
DNA lesions in addition to pyrimidine dimers, the substrates
of the encoded photolyase (15). This observation, in con-
junction with our demonstration that deletion ofURSPHR1 has
a similar effect on the response to damage generated by UV
radiation or by exposure to the alkylating agent methyl
methanesulfonate, suggests that PRP is part of a regulatory
pathway that responds to multiple damaging agents. Is PRP
involved in the regulation of other damage-responsive genes
in yeast? The sequences required for damage responsiveness
have been identified for two yeast DNA repair genes, RAD2
(nucleotide excision repair) and RAD54 (recombination and
double-strand break repair), and the RNR2 and RNR3 genes,
which encode subunits of ribonucleotide reductase. Deletion
analysis of the RAD2 and RAD54 promoters has established
that the damage response is positively regulated by different
UASs (30, 31), whereas both positive and negative control
elements are involved in the regulation of RNR2 and RNR3
(32-34). None of the damage-responsive elements identified
by these analyses display significant homology to the 39-bp
URSPHR1 as a whole or to the 22-bp inverted repeat, nor is the
recently reported sequence homology found 5' ofRAD6 and
RAD18 included within URSPHR1 (35). However, this obser-
vation is subject to several caveats. Although we have
defined the region protected by PRP, we have not yet
identified which bases within this region are actually required
for PRP binding; if the required contacts are few in number
or widely scattered within the protected region, similarities
between URSPHR1 and other damage-responsive elements
could easily be obscured. In addition there are now several
well-documented examples of transcription regulators that
are capable of recognizing and binding to unrelated or highly
degenerate sequences (36, 37). The results of studies to define
the sequence requirements for PRP binding should permit a
more definitive assessment of the role of PRP as a general
regulator ofdamage-responsive genes in yeast. In addition we
note that there is a good match between the sequence
AGGNATTRAA (where N is any nucleotide and R is a
purine), found in both UAS1 and UAS2 of the RAD2 gene
(30), and the sequence AGGGGTGAAA located within the
PRP-protected region at positions -77 through -68. While
the size and location of this region within URSPHR1 make it
unlikely that it alone is responsible for PRP binding, it is
possible that this region constitutes a damage-responsive
UAS that is masked by PRP binding during normal growth,
an issue not addressed in the experiments reported here.
The search for common regulators of damage-responsive
genes in eukaryotes has focused primarily on sequences
upstream from these genes as potential binding sites for
shared transcription regulators. However, it is equally pos-
sible that common regulation occurs at a higher level, for
example, through damage-responsive modification of multi-
ple DNA binding proteins that present common targets for
modification but recognize different base sequences. At
present the specific steps involved in the DNA damage signal
transduction pathway are entirely unknown. Identification of
the damage-responsive repressorPRP and its cognate binding
site URSPHRL reported here may ultimately permit the genetic
and biochemical studies required to resolve these issues.
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